Study of the brain serotonergic system with labeled α‐methyl‐l‐tryptophan

alpha-Methyl-L-tryptophan (alpha-MTrp) is an artificial amino acid and an analog of tryptophan (Trp), the precursor of the neurotransmitter serotonin (5-HT). In this article we have summarized available data, which suggest that the measurement of the unidirectional uptake of alpha-MTrp and its conversion to 5-HT synthesis rates is a valid approach for the determination of brain 5-HT synthesis rates. The main feature on which the model is based is the trapping of labeled alpha-MTrp in brain tissue. An overview of opposing opinions, which suggest that there is a need for a metabolic conversion of tracer, is also presented and discussed critically. As with all biological modeling there is likely to be room for improvements of the proposed biological model. In addition, there are a limited number of clearly defined circumstances in which the method is confounded by the metabolism of labeled alpha-MTrp via the kynurenine pathway. Nonetheless, a significant body of evidence suggests that labeled alpha-MTrp is a useful tracer to study brain 5-HT synthesis in most circumstances. Calculation of 5-HT synthesis rates depends on the plasma-free tryptophan concentration, which, according to the balance of arguments in the literature, is a more appropriate parameter than the total-plasma tryptophan. The method, as proposed by us, can be used in conjunction with autoradiographic measurements in laboratory animals, and with positron emission tomography in large animals and humans. We review studies in animals looking at the normal control of 5-HT synthesis and the way in which it is altered by drugs, as well as initial studies investigating healthy humans and patients with neuropsychiatric disorders.

[1]  G. Curzon,et al.  A STUDY OF PROPOSED DETERMINANTS OF BRAIN TRYPTOPHAN CONCENTRATION IN RATS AFTER PORTOCAVAL ANASTOMOSIS OR SHAM OPERATION , 1978, Journal of neurochemistry.

[2]  O. Hayaishi,et al.  6R-L-erythro-5,6,7,8-tetrahydrobiopterin as a regulator of dopamine and serotonin biosynthesis in the rat brain. , 1985, Archives of biochemistry and biophysics.

[3]  S. Yeh,et al.  Quantitive aspects of cycloheximide inhibition of amino acid incorporation. , 1969, Biochemical pharmacology.

[4]  M Diksic Does labeled alpha-methyl-L-tryptophan image ONLY blood-brain barrier transport of tryptophan? , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  A. Crane,et al.  Stimulation of protein synthesis and glucose utilization in the hypoglossal nucleus induced by axotomy , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  O Muzik,et al.  Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. , 1998, Synapse.

[7]  H. Okazawa,et al.  Effects of Acute and Chronic Administration of the Serotonin1A Agonist Buspirone on Serotonin Synthesis in the Rat Brain , 1999, Journal of neurochemistry.

[8]  C. de Montigny,et al.  Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors , 1998, The Journal of Neuroscience.

[9]  P. A. Shore,et al.  The reserpine receptor. , 1978, Life sciences.

[10]  T. Sourkes,et al.  Alpha-methyltryptophan: effects on synthesis and degradation of serotonin in the brain. , 1972, Neuropharmacology.

[11]  Peggy Dean,et al.  Mood Response to Acute Tryptophan Depletion in Healthy Volunteers: Sex Differences and Temporal Stability , 1996, Neuropsychopharmacology.

[12]  T. Joh,et al.  Acute effects of reserpine on tryptophan hydroxylase activity and mRNA in rat brain , 1993, Brain Research.

[13]  M. Diksic,et al.  The Rate of Valine Incorporation into Proteins with Correction for Valine Recycling, Measured in Two Brain Tumor Models and the Cortex , 1996, Journal of neurochemistry.

[14]  A. Mandell,et al.  Regulation of serotonin biosynthesis in brain: role of the high affinity uptake of tryptophan into serotonergic neurons. , 1977, Federation proceedings.

[15]  In vivo measurement of 5-hydroxytryptamine turnover rate in the rat brain from the conversion of C14-tryptophan to C14-5-hydroxytryptamine. , 1969, The Journal of pharmacology and experimental therapeutics.

[16]  D. Cohen,et al.  Serotonin in human lumbar cerebrospinal fluid: a reassessment. , 1990, Life sciences.

[17]  F. Hirata,et al.  Indoleamine 2,3-dioxygenase. Purification and some properties. , 1978, The Journal of biological chemistry.

[18]  G. Biggio,et al.  Daily changes of free serum tryptophan in humans. , 1974, Life sciences.

[19]  M. Diksic,et al.  Effect of Acute Fluoxetine Treatment on the Brain Serotonin Synthesis as Measured by the α‐Methyl‐l‐Tryptophan Autoradiographic Method , 1995, Journal of neurochemistry.

[20]  R. Salomon,et al.  Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action , 1999, Biological Psychiatry.

[21]  D G Grahame-Smith,et al.  5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis , 1989, British journal of pharmacology.

[22]  M Diksic,et al.  Image generation of serotonin synthesis rates using alpha-methyltryptophan and PET. , 1998, Journal of computer assisted tomography.

[23]  K. Norwich Molecular Dynamics in Biosystems: The Kinetics of Tracers in Intact Organisms , 1977 .

[24]  B. Madras,et al.  Metabolism of a-methyltryptophan? , 1965 .

[25]  J. Harvey,et al.  Differences in the duration of reserpine action in the rat depending on the measure employed. , 1968, International journal of neuropharmacology.

[26]  S. Ross,et al.  A and B Forms of Monoamine Oxidase Within the Monoaminergic Neurons of the Rat Brain , 1986, Journal of neurochemistry.

[27]  A. Luxen,et al.  Biochemical and Autoradiographic Measurements of Brain Serotonin Synthesis Rate in the Freely Moving Rat , 1999, Journal of neurochemistry.

[28]  M. D. Faiman,et al.  Effect of high oxygen pressure on brain norepinephrine and serotonin turnover. , 1973, European journal of pharmacology.

[29]  M Diksic,et al.  Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Klaus P. Ebmeier,et al.  Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users , 1999, British Journal of Psychiatry.

[31]  Peter Herscovitch,et al.  The Suitability of [11C]-α-Methyl-L-tryptophan as a Tracer for Serotonin Synthesis: Studies With Dual Administration of [11C] and [14C] Labeled Tracer , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  M Diksic,et al.  Labelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic system. , 2001, Journal of psychiatry & neuroscience : JPN.

[33]  P. Cowen,et al.  Dieting reduces plasma tryptophan and alters brain 5-HT function in women , 1990, Psychological Medicine.

[34]  J. Long,et al.  Regional differences in the response of serotonergic neurons in rat CNS to drugs. , 1983, European journal of pharmacology.

[35]  M. Diksic,et al.  The Acute Effects of Reserpine and NSD-1015 on the Brain Serotonin Synthesis Rate Measured by an Autoradiographic Method , 1995, Neuropsychopharmacology.

[36]  E. Major,et al.  A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. , 1993, Brain : a journal of neurology.

[37]  M. Diksic,et al.  The Regional Rate of Serotonin Synthesis Estimated by the α-Methyl-Tryptophan Method in Rat Brain from a Single Time Point , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  A. Gjedde,et al.  Rapid steady-state analysis of blood-brain transfer of l-Trp in rat, with special reference to the plasma protein binding , 1993, Neurochemistry International.

[39]  D. Hommer,et al.  Brain Serotonin Synthesis Rates in Rhesus Monkeys Determined by [11C;[alpha;-Methyl-L-Tryptophan and Positron Emission Tomography Compared to CSF 5-Hydroxyindole-3-Acetic Acid Concentrations , 1998, Neuropsychopharmacology.

[40]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[41]  C. McDougle,et al.  Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.

[42]  R. Cohen Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  K. Worsley,et al.  Determination of the Lumped Constant for the α‐Methyltryptophan Method of Estimating the Rate of Serotonin Synthesis , 1995, Journal of neurochemistry.

[44]  G. Sarwar,et al.  A comparison of fasting serum amino acid profiles of young and elderly subjects. , 1991, Journal of the American College of Nutrition.

[45]  S. Rapoport,et al.  Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier , 1987, Journal of neurochemistry.

[46]  M. Diksic,et al.  Brain net unidirectional uptake of alpha-[14c]methyl-L-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp. , 2000, Neurochemical research.

[47]  M. Diksic,et al.  The Transfer Coefficients for L-Valine and the Rate of Incorporation of L-[1-14C] Valine into Proteins in Normal Adult Rat Brain , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  J. Downing The psychological and physiological effects of MDMA on normal volunteers. , 1986, Journal of psychoactive drugs.

[49]  D. X. Freedman,et al.  Loss of body weight as a predictor of reserpine-induced amine depletion. , 1975, European journal of pharmacology.

[50]  G. Aghajanian,et al.  Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. , 1990, Archives of general psychiatry.

[51]  S. Young The clinical psychopharmacology of tryptophan , 1986 .

[52]  S. Markey,et al.  Kynurenine Pathway Enzymes in Brain: Responses to Ischemic Brain Injury Versus Systemic Immune Activation , 1993, Journal of neurochemistry.

[53]  J. Oncley,et al.  The specific binding of L-tryptophan to serum albumin. , 1958, The Journal of biological chemistry.

[54]  E. Hamel,et al.  Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: Retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion , 1999, Synapse.

[55]  J. Wood Neurochemical analysis of cerebrospinal fluid , 1980, Neurology.

[56]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  M. Diksic,et al.  Influence of Fluoxetine on Regional Serotonin Synthesis in the Rat Brain , 1996, Journal of neurochemistry.

[58]  M. Diksic,et al.  Synthesis of Serotonin in Traumatized Rat Brain , 1995, Journal of neurochemistry.

[59]  M. Diksic,et al.  Biological model for the in vivo measurement of rate of serotonin synthesis in the brain. , 1990, Journal of neural transmission. Supplementum.

[60]  M. Demitrack,et al.  Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.

[61]  Roger N. Gunn,et al.  Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.

[62]  M. Salter,et al.  How does displacement of albumin-bound tryptophan cause sustained increases in the free tryptophan concentration in plasma and 5-hydroxytryptamine synthesis in brain? , 1989, The Biochemical journal.

[63]  O Muzik,et al.  Imaging epileptogenic tubers in children with tuberous sclerosis complex usingα‐[11C]Methyl‐L‐tryptophan positron emission tomography , 1998, Annals of neurology.

[64]  Mirko Diksic Does Labeled α-Methyl-L-Tryptophan Image ONLY Blood–Brain Barrier Transport of Tryptophan? , 2000 .

[65]  B. Goldstein,et al.  Comparison of Buspirone and Diazepam in Generalized Anxiety Disorder , 1985, Pharmacotherapy.

[66]  D. Stefoski,et al.  Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man , 1977, Journal of the Neurological Sciences.

[67]  T. Sourkes Alpha-methyltryptophan and its actions on tryptophan metabolism. , 1971, Federation proceedings.

[68]  M Schulzer,et al.  Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  M. Diksic,et al.  Autoradiographic evaluation of the influence of hypothalamic 5,7-dihydroxytryptamine lesion on brain serotonin synthesis. , 1995, Biochemical pharmacology.

[70]  A. Beaudet,et al.  In vivo‐synthesized radioactively labelled α‐methyl serotonin as a selective tracer for visualization of brain serotonin neurons , 1995, Synapse.

[71]  W. Pardridge Brain metabolism: a perspective from the blood-brain barrier. , 1983, Physiological reviews.

[72]  D. Faulds,et al.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. , 1996, Drugs.

[73]  T. Sourkes,et al.  Functional cerebral activity of an analogue of serotonin formed in situ , 1988, Neurochemistry International.

[74]  S. Kapur,et al.  Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals , 1999, Neuroscience Letters.

[75]  M. Diksic,et al.  A new method to measure brain serotonin synthesis in vivo. II. A practical autoradiographic method tested in normal and lithium-treated rats. , 1990 .

[76]  S. Gauthier,et al.  Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. , 1981, Journal of neurology, neurosurgery, and psychiatry.

[77]  P. Blier,et al.  Autoregulation of serotonin neurons: role in antidepressant drug action. , 1999, Pharmacological reviews.

[78]  L. Bertilsson 5-Hydroxyindoleacetic acid in cerebrospinal fluid--methodological and clinical aspects. , 1987, Life sciences.

[79]  R. Wurtman,et al.  Plasma amino acid concentrations in healthy elderly men and women. , 1991, The American journal of clinical nutrition.

[80]  T. Sourkes,et al.  REGIONAL TRANSPORT OF TRYPTOPHAN IN RAT BRAIN , 1977, Journal of neurochemistry.

[81]  J. Fenstermacher,et al.  Theoretical Considerations in the Chemotherapy of Brain Tumors , 1974 .

[82]  O. Muzik,et al.  α[C-11]Methyl-l-Tryptophan PET Maps Brain Serotonin Synthesis and Kynurenine Pathway Metabolism , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[83]  K. Tipton,et al.  Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain , 1982, Journal of neurochemistry.

[84]  R. Wurtman,et al.  Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels , 1971, Science.

[85]  R. Rothermel,et al.  Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children , 1999, Annals of neurology.

[86]  W. Oldendorf,et al.  Kinetic Constants for Blood—Brain Barrier Amino Acid Transport in Conscious Rats , 1985, Journal of neurochemistry.

[87]  E. Azmitia,et al.  An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat , 1978, The Journal of comparative neurology.

[88]  M. Diksic,et al.  A New Method to Measure Brain Serotonin Synthesis in vivo. I. Theory and Basic Data for a Biological Model , 1990 .

[89]  J. Priess,et al.  Biological Model , 2020, Definitions.

[90]  H. Tamir,et al.  STORAGE OF SEROTONIN AND SEROTONIN BINDING PROTEIN IN SYNAPTIC VESICLES , 1979, Journal of neurochemistry.

[91]  O Muzik,et al.  Analysis of [C-11]Alpha-Methyl-Tryptophan Kinetics for the Estimation of Serotonin Synthesis Rate In Vivo , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[92]  M. Diksic,et al.  Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography , 1999, Neurochemistry International.

[93]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[94]  S. Hjorth,et al.  Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. , 1982, European journal of pharmacology.

[95]  D. Faller,et al.  Tryptophan concentrations in rat brain. Failure to correlate with free serum tryptophan or its ratio to the sum of other serum neutral amino acids. , 1976, The Biochemical journal.

[96]  W H Oldendorf,et al.  TRANSPORT OF METABOLIC SUBSTRATES THROUGH THE BLOOD‐BRAIN BARRIER 1 , 1977, Journal of neurochemistry.

[97]  A. Carlsson,et al.  Brain Tryptophan Hydroxylation: Dependence on Arterial Oxygen Tension , 1973, Science.

[98]  O. Muzik,et al.  Increased brain serotonin synthesis in migraine. , 1999, Neurology.

[99]  C. P. Vandermaelen,et al.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. , 1986, European journal of pharmacology.

[100]  T. Chaly,et al.  Serotonin Synthesis Rate Measured in Living Dog Brain by Positron Emission Tomography , 1991, Journal of neurochemistry.

[101]  Roger N. Gunn,et al.  Tracer Kinetic Modelling of the 5-HT1A Receptor Ligand [carbonyl-11C]WAY-100635 , 1998, NeuroImage.

[102]  Z. Szabo,et al.  Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings , 1998, The Lancet.

[103]  C S Patlak,et al.  Methods for Quantifying the transport of drugs across brain barrier systems. , 1981, Pharmacology & therapeutics.

[104]  L. Sokoloff Neurophysiology and neurochemistry of coma. , 1971, Experimental biology and medicine.

[105]  C. Halldin,et al.  Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[106]  H. Okazawa,et al.  Validation of a Less-Invasive Method for Measurement of Serotonin Synthesis Rate with α-[11C]Methyl-Tryptophan , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[107]  M. Wilson,et al.  Neurotoxicity of MDMA and Related Compounds: Anatomic Studies a , 1990, Annals of the New York Academy of Sciences.

[108]  M. Diksic,et al.  The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study , 1998, Brain Research.